Human peritoneal mesothelial cells isolated from spent dialysate fluid maintain contaminating macrophages via production of macrophage colony stimulating factor

Nephrology

Volumn 12, Issue 2, 2007, Pages 160-165

  Tee, Melinda M ^a,b   Tesch, Gregory H ^a,b   Nikolic Paterson, David J ^a,b   Brown, Fiona G ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Dialysate; Human; Macrophage; Mesothelial; Peritoneal

Indexed keywords

BROXURIDINE; CALRETININ; COLONY STIMULATING FACTOR 1; CYTOKERATIN 18; CYTOKERATIN 8; CYTOKINE; OXIDOREDUCTASE;

ARTICLE; CELL CULTURE; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; CENTRIFUGATION; CONTROLLED STUDY; DIALYSATE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HUMAN; HUMAN CELL; LEUKOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; PERITONEUM CELL; PRIORITY JOURNAL; SUPERNATANT;

ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL PROLIFERATION; CELL SEPARATION; CULTURE MEDIA, CONDITIONED; DIALYSIS SOLUTIONS; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; KERATIN-18; KERATIN-8; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES, PERITONEAL; PARACRINE COMMUNICATION; PERITONEAL DIALYSIS; PERITONEUM; PHENOTYPE; TIME FACTORS;

EID: 33947220911     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00760.x     Document Type: Article

References (23)

1. Mutsaers SE. Mesothelial cells: Their structure, function and role in serosal repair. Respirology 2002; 7: 171-91.
2. Nevado J, Peiro C, Vallejo S et al. Amadori adducts activate nuclear factor-kappaB-related proinflammatory genes in cultured human peritoneal mesothelial cells. Br. J. Pharmacol. 2005; 146: 268-79.
3. Yung S, Chen XR, Tsang RC, Zhang Q, Chan TM. Reduction of perlecan synthesis and induction of TGF-beta1 in human peritoneal mesothelial cells due to high dialysate glucose concentration: Implication in peritoneal dialysis. J. Am. Soc. Nephrol. 2004; 15: 1178-88.
4. Hausmann MJ, Rogachev B, Weiler M, Chaimovitz C, Douvdevani A. Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth. Kidney Int. 2000; 57: 476-86.
5. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J. Am. Soc. Nephrol. 2001; 12: 1046-51.
6. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J. Am. Soc. Nephrol. 2002; 13: 470-79.
7. Zareie M, De Vriese AS, Hekking LH et al. Immunopathological changes in a uraemic rat model for peritoneal dialysis. Nephrol. Dial. Transplant. 2005; 20: 1350-61.
8. Combet S, Ferrier ML, Van Landschoot M et al. Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. J. Am. Soc. Nephrol. 2001; 12: 2146-57.
9. Yanez-Mo M, Lara-Pezzi E, Selgas R et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N. Engl. J. Med. 2003; 348: 403-13.
10. Aroeira LS, Aguilera A, Selgas R et al. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: Role of vascular endothelial growth factor. Am. J. Kidney Dis. 2005; 46: 938-48.
11. Do JY, Kim YL, Park JW et al. The effect of low glucose degradation product dialysis solution on epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis patients. Perit. Dial. Int. 2005; 25 (Suppl. 3): S22-5.
12. Faull RJ, Stanley JM, Fraser S, Power DA, Leavesley DI. HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration. Kidney Int. 2001; 59: 614-24.
13. Catalan MP, Subira D, Reyero A et al. Regulation of apoptosis by lethal cytokines in human mesothelial cells. Kidney Int. 2003; 64: 321-30.
14. Kraft N, Stein-Oakley A, Bal J, Atkins RC, Thomson NM. Effect of anti-common leucocyte (CD45R, CD45) monoclonal antibodies on human lymphocyte activation: Their potential for modifying kidney dendritic cells. Transplant. Proc. 1989; 21: 1023-5.
15. Lan HY, Hutchinson P, Tesch GH, Mu W, Atkins RC. A novel method of microwave treatment for detection of cytoplasmic and nuclear antigens by flow cytometry. J. Immunol. Methods 1996; 190: 1-10.
16. Leavesley DI, Stanley JM, Faull RJ. Epidermal growth factor modifies the expression and function of extracellular matrix adhesion receptors expressed by peritoneal mesothelial cells from patients on CAPD. Nephrol. Dial. Transplant. 1999; 14: 1208-16.
17. Barreda DR, Hanington PC, Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev. Comp. Immunol. 2004; 28: 509-54.
18. Muller J, Yoshida T. Interaction of murine peritoneal leukocytes and mesothelial cells: in vitro model system to survey cellular events on serosal membranes during inflammation. Clin. Immunol. Immunopathol. 1995; 75: 231-8.
19. Lanfrancone L, Boraschi D, Ghiara P et al. Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1. Blood 1992; 80: 2835-42.
20. Fieren MW. Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis. Blood Purif. 1996; 14: 179-87.
21. Pertynska-Marczewska M, Kiriakidis S,Wait R, Beech J, Feldmann M, Paleolog E. Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Cytokine 2004; 28: 35-47.
22. Sikkink CJ, Reijnen MM, Falk P, van Goor H, Holmdahl L. Influence of monocyte-like cells on the fibrinolytic activity of peritoneal mesothelial cells and the effect of sodium hyaluronate. Fertil. Steril. 2005; 84: 1072-7.
23. Chegini N. The role of growth factors in peritoneal healing: Transforming growth factor beta (TGF-beta). Eur. J. Surg. Suppl. 1997; 577: 17-23.